Search results
Anonymous donor gives Valley Children’s $15 million to fund cancer treatment, hospital says
Fresno Bee via Yahoo News· 4 hours agoThe gift, given amidst criticism of its executive pay levels, is one of the largest single donations...
Alka Dwivedi
Time Magazine· 10 hours agoFind out why Alka Dwivedi is on the TIME100 Health list.
Sylvester Cancer Adding Cellular Therapy to Its Arsenal Against Metastatic Melanoma
Newswise· 2 days agoPatients in South Florida with metastatic melanoma will soon have access to the first cellular ...
Astellas hitches a ride in Poseida's convertible for $50M cell therapy collaboration
FierceBiotech· 1 day agoThe companies have signed an agreement, via Astellas’ subsidiary Xyphos Biosciences, to develop two...
Anonymous donor gives Valley Children’s $15 million to fund cancer treatment, hospital says
The Fresno Bee· 4 hours agoA $15 million donation to Valley Children’s Hospital from an anonymous donor will be used to create...
Trials to watch: Four ALS drugs to keep an eye on
Clinical Trials Arena via Yahoo Finance· 2 days agoThe trial is an open-label, non-randomised, multi-centre study evaluating RAPA-501 T cell therapy in patients with ALS. RAPA-501 is an ...
Novel T-cell engager, CDH17 X CD3 cabotamig (ARB202) continues to explore dosing in patients with...
FOX 59 Indianapolis· 6 days agoThe DMC review confirms the safety risk profile of cabotamig being consistent with published T-cell...
Researchers discover how immune B cells hunt down cancer around the body
Medical Xpress· 3 hours agoAs published in Nature Immunology, the researchers have developed a computational tool to identify these anti-cancer immune cells, which could lead to improved, personalized immunotherapies.
Component of keto diet plus immunotherapy may reduce prostate cancer
Medical Xpress· 5 days agoICB therapy blocks certain proteins from binding with other proteins and paves the way for our...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 2 days agoReplay and MD Anderson announce FDA clearance of IND application for first-in-class PRAME-targeted T-Cell Receptor Natural Killer (TCR-NK) cell
